CERTIFICATE OF NOTIFICATION
filed by
GEORGIA POWER COMPANY
Pursuant to order of the Securities and Exchange Commission
dated December 15, 1993, in the matter of File No. 70-8085.
Georgia Power Company ("GEORGIA") hereby certifies to said
Commission, pursuant to Rule 24, that, in accordance with the
terms and conditions of and for the purposes represented by the
statement on Form U-1, as amended, and of said order with respect
thereto the following information is provided.
1. List of each Partnership Portfolio Company.
AtheroGenics
2. Fair Market Value of Partnership's Investment.
$159,862
3. General description of the business activities of each such
Partnership Portfolio Company.
AtheroGenics, Inc. (a Georgia-based company) is engaged in
the development of novel biopharmaceuticals and diagnostic
markers which address cardiovascular disease and its
intervention.
4. Aggregate amount invested by GEORGIA in the Partnership
during such semi-annual period (July 1994 - December 1994).
None
5. GEORGIA's aggregate investment in the Partnership at end of
December 31, 1994.
$750,000
Dated: February 15, 1995 GEORGIA POWER COMPANY
By: Wayne Boston
Wayne Boston
Assistant Secretary<PAGE>
